Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Original research] [Experimental medicine]
Elena Petrovna Golubinskaya; Tatyana Grigorievna Filonenko; Julianna Arkadevna Yermola; Anatoly Vladimirovich Kubyshkin; Margarita Alekseevna Kalfa; Alina Vitalevna Gerashchenko; Tatyana Vadimovna Kramar; Elizaveta Sergeevna Ageeva;
A morphological assessment of 163 fragments of the cavity’s wall and pericavernous lung tissue of the dead or operated on patients with verified fibro-cavernous pulmonary tuberculosis with both bacterial excretion and clinical abacillation was carried out using the transmission electron microscopy method. It has been established that in cases of active tuberculosis, destructive processes in the cavern wall and pericavernosal zone predominate. It’s accompanied by an intensification of lymphohistiocytic activity, increasing of interstitial and intracellular edema, loosening of the basal membranes, uncontrolled increasing of hemocapillary permeability and subsequent organization of exudates. The stabilization of the tuberculous process is accompanied by sclerosis and interstitial fibrosis with the formation of the alveolar-capillary block, dystrophic processes in endotheliocytes and alveolar epithelial cells, chemotaxis of fibroblasts and activation of their synthetic collagen activity. It seems that the prevention of progressive fibrotic remodeling of the pulmonary parenchyma should be based on pathogenetically substantiated target therapy, which provides normalization of the functional activity of endothelium cells and the aerohematic barrier of the lungs, and sanogenetic support of the surfactant structure.
References:
1. Vasilyeva N. R., Vyazovaya A. A., Zhuravlev V. Yu., Solovyeva N. S., Mokrousov I. V. [et al.]. Genotipy shtammov Mycobacterium tuberculosis s shirokoy lekarstvennoy ustoychivostyu i klinikoepidemiologicheskiye osobennosti tuberkuleza legkikh. Infektsiya i immunitet. – Infection and immunity.2016;6(2):179-183. (In Russ.).
2. Scordo J. M., Knoell D. L., Torrelles J. B. Alveolar epithelial cells in Mycobacterium tuberculosis infection: active players or innocent by standers. Journal of Innate Immunity.2016;8(1):3-14.https://doi.org/10.1159/000439275
3. Cronan M. R., Beerman R. W., Rosenberg A. F., Saelens J. W., Johnson M. G. [et al.]. Macrophage epithelial reprogramming underlies mycobacterial granuloma formation and promotes infection. Immunity. 2016;45(4):861-876. https://doi.org/10.1016/j.immuni.2016.09.014
Ahluwalia P. K., Pandey R. K., Sehajpal P. K., Prajapati V. К. Perturbed microRNA expression by Mycobacterium tuberculosis promotes macrophage polarization leading to pro-survival foam cell. Frontiers in Immunology. 2017;8:107.https://doi.org/10.3389/fimmu.2017.00107
5. Shouxiong H. Targeting innate-like T-сells in tuberculosis. Frontiers in Immunology. 2016;7:594. https://doi.org/10.3389/fimmu.2016.00594
6. Coppola M., van den Eeden S. J., Wilson L., Franken K. L., Ottenhoff T. H. [et al.]. Synthetic long peptide derived from Mycobacterium tuberculosis latency antigen Rv1733c protects against tuberculosis. Clinical and Vaccine Immunology. 2015;22(9):1060-1069. https://doi.org/10.1128/CVI.00271-15
7. Elipashev A. A., Nikolskiy V. O., Shprykov A. S. Morfologicheskiye priznaki aktivnosti
vospaleniya pri razlichnykh klinicheskikh formakh ekarstvenno-ustoychivogo tuberkuleza. Arkhiv patologii. Archive of pathology. 2017;79(4):13-17. (In Russ.). https://doi.org/10.17116/patol201779413-17
8. Golubinskaya E. P., FilonenkoT. G., Kalfa M. A., Ermola Yu. A. Morfofunktsionalnyye osobennosti angiogeneza prifibrozno-kavernoznom tuberkuleze legkikh. Krymskiy zhurnal eksperimentalnoy i klinicheskoy meditsiny. Crimean Journal of Experimental and Clinical Medicine. 2018;8(1):16-19. (In Russ.).
9. Yablonskiy P. K., Vishnevskiy B. I., Solovyeva N. S., Manicheva O. A., Dogonadze M. Z. [et al.]. Lekarstvennaya ustoychivost Mycobacterium tuberculosis pri razlichnykh lokalizatsiyakh
zabolevaniya. Infektsiya i immunitet. – Infection and immunity. 2016;6(2):133-140. (In Russ.)].
10. Bayke E. E., Bogodukhova E. S., Bayke E. V. Geneticheskiy polimorfizm pro- i
protivovospalitelnykh tsitokinov u bolnykh tuberkulezom. Smolenskiy meditsinskiy almanakh. – Smolensk Medical Almanac. 2015;(3):169-173. (In Russ.).
11. Kashtalyan O. A., Ushakova L. Yu. Tsitokiny kak universalnaya sistema regulyatsii. Meditsinskiye novosti. – Medical news. 2017;(9):3-7. (In Russ.).
12. Popova L. A., Shergina E. A., Lovacheva O. V., Shabalina I. Yu., Bagdasaryan T. R. [et
al.]. Izmeneniya funktsionalnogo statusa legkikh v ranniy period endoskopicheskoy klapannoy bronkhoblokatsii u bolnykh khronicheskim destruktivnym tuberkulezom. Pulmonoloiya. – Pulmonology. 2018;28(3):332-340. (In Russ.). https://doi.org/10.18093/0869-0189-2018-28-3-332-340
13. Kovalenko E. I., Streltsova M. A. Adaptivnyye svoystva naturalnykh killerov – limfotsitov
vrozhdennogo immuniteta. Bioorganicheskaya khimiya. Bioorganic chemistry. 2016;42(6):649-667. (In Russ.). https://doi.org/10.7868/S0132342316060063
Keywords: fibrous-cavernous tuberculosis, alveolocytes, endothelial cells, aerohematic barrier, electron microscopy